SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-045468
Filing Date
2022-02-17
Accepted
2022-02-17 16:15:56
Documents
12
Period of Report
2022-02-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d504750d8k.htm   iXBRL 8-K 22520
  Complete submission text file 0001193125-22-045468.txt   144054

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stok-20220211.xsd EX-101.SCH 2888
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20220211_lab.xml EX-101.LAB 17980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20220211_pre.xml EX-101.PRE 11280
6 EXTRACTED XBRL INSTANCE DOCUMENT d504750d8k_htm.xml XML 3341
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 22648292
SIC: 2834 Pharmaceutical Preparations